Terms: = Breast cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Staging
3 results:
1. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian breast cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract] [Full Text] [Related]
2. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive breast cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
Kim WH; Kim HJ; Park HY; Park JY; Chae YS; Lee SM; Cho SH; Shin KM; Lee SY
Ultrasound Med Biol; 2019 Mar; 45(3):702-709. PubMed ID: 30567630
[TBL] [Abstract] [Full Text] [Related]
3. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB
Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871
[TBL] [Abstract] [Full Text] [Related]
